Raymond T. Keane, SVP General Counsel & CCO at ARIAD PHARMACEUTICALS INC (ARIA), sold 10,533 shares at $15.41 ($162K) on 2012-03-23, disclosed to the SEC on 2012-03-26.
Scheduled sale ($162k) by SVP General Counsel & CCO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ARIA | SELL | 2013-03-26 | $248K | — | Filing → |
| ARIA | SELL | 2013-03-22 | $45K | — | Filing → |
| ARIA | SELL | 2012-09-07 | $220K | — | Filing → |